Hospitals And Newborn Drug Testing: Why And When?

do hospitals do drug tests on newborns

Drug testing procedures for newborns vary across hospitals and states. While there are no standardized requirements for hospitals to test newborns, hospitals typically take a risk-based approach to testing infants, considering factors such as maternal history of substance use disorder. Testing methods include using samples from urine, meconium, blood, hair, umbilical cord blood, or tissue samples. Some states have legislation to protect infants, with varying consequences for mothers who test positive, including criminal charges or involvement of child protective services. Hospitals are increasingly aiming to reduce the punitive response to substance use during pregnancy, encouraging open conversations and providing resources to support pregnant women.

Characteristics Values
Standardized drug testing requirements There are no standardized drug testing requirements that mandate hospitals to test pregnant women or their newborns.
Reporting In most states and situations, OBGYN physicians and hospital workers do report failed drug screens and even suspected drug use of pregnant women to state agencies.
State laws Each state is different for newborn drug testing laws.
Testing methods Hospitals test newborns using samples from urine, meconium, blood, hair, umbilical cord blood or tissue samples.
Testing reasons Hospitals typically take a risk-based approach to testing infants. Medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of substance abuse.
Testing frequency There is no specific frequency mentioned, but it depends on the hospital's policies and protocols.
Patient consent Physicians are supposed to have informed consent before drug testing a pregnant patient. However, drug testing without consent does happen.
Refusing testing In many states, including Illinois, patients may refuse a drug screen even if drug or alcohol use is suspected.
Consequences of positive tests The consequences could involve removing the child from maternal custody through the state or an agency like child protective services.

shunhospital

Testing methods

There are no standardized drug testing requirements that mandate hospitals to test pregnant women or their newborns. Hospitals typically take a risk-based approach to testing infants. Medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of substance abuse.

Testing of newborns is done using samples from urine, meconium, blood, hair, umbilical cord blood, or tissue samples. Meconium is the traditional specimen for newborn drug testing, although its use may pose pre-analytic challenges, such as delayed or segmented collection. Umbilical cord tissue is easily collected at birth but has been found to contain lower drug concentrations than meconium. Urine, hair, and blood (including umbilical cord blood) tests offer different advantages, disadvantages, and windows of detection in newborn drug screening. The use of various specimen types is intended to complement the investigation of potential newborn drug exposure.

Universal specimen collection (i.e., with testing only as needed) may occur based on institutional, local, or state policy. When testing is indicated, it typically entails the same methods used in adult drug testing, such as mass spectrometry (MS) and immunoassay. MS, which has a high level of sensitivity and specificity, is widely used for initial testing but can also be used to confirm a previous test result. Immunoassays may also be used for initial testing, but due to their potential for cross-reactivity, these tests may require confirmation when results are positive or unanticipated.

If hospitals test the meconium (the baby's first feces), alcohol can be detected if it was used up to 5 months before delivery. Blood and urine testing would only detect recent alcohol use within the past 2-3 days. If meconium is tested for alcohol, it can reveal the severity of the alcohol use (i.e., heavy daily use vs. occasional use).

shunhospital

Testing requirements

There are no standardized drug testing requirements that mandate hospitals to test pregnant women or their newborns. Hospitals typically take a risk-based approach to testing infants, and it is usually up to doctors and hospital protocol to determine when to perform drug tests. Medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of substance abuse.

Testing of newborns is done using samples from urine, meconium, blood, hair, umbilical cord blood, or tissue samples. Meconium is the traditional specimen for newborn drug testing, although its use may pose pre-analytic challenges. Umbilical cord tissue is easily collected at birth but has been found to contain lower drug concentrations than meconium. Urine, hair, and blood (including umbilical cord blood) tests offer different advantages, disadvantages, and windows of detection in newborn drug screening.

In the United States, there is no federal law requiring drug testing of newborns, and the decision to test is often left to individual states, hospitals, or medical institutions. Only four states (North Dakota, Minnesota, Iowa, and Kentucky) require hospitals to test both new mothers and their children if medical professionals suspect drug use. In some states, women can be charged criminally, while other states consider it child abuse and involve Child Protective Services.

Each hospital sets its own protocols around how and when newborn testing occurs. Hospitals are required to report any exposures to Child Protective Services (CPS) under the Child Abuse Prevention and Treatment Act (CAPTA). Testing the meconium (the baby's first feces) is common and can detect drug and alcohol use in the last 4 to 5 months of pregnancy. Blood and urine testing would only detect recent alcohol or drug use within the past 2 to 3 days.

Some hospitals are changing their response when babies are born exposed to drugs, aiming to decrease the punitive response to substance use during pregnancy. For example, Massachusetts' largest healthcare system, Mass General Brigham, announced that it will no longer report suspected abuse or neglect to state welfare officials simply because a baby is born exposed to drugs. Instead, a report will be triggered only if there is reasonable cause to believe that the infant is "suffering or at imminent risk of suffering physical or emotional injury."

shunhospital

State laws

In most states, OBGYN physicians and hospital workers are required to report suspected or confirmed drug use by pregnant women to state agencies. However, alcohol use is less likely to be reported. While reporting is not always mandated, it can help pregnant women access resources to stop substance use. Results of newborn drug and alcohol screens are mandated to be reported.

Some states have specific laws that criminalise drug use during pregnancy. Tennessee is the only state with a statute that specifically makes it a crime to use drugs while pregnant. Alabama and South Carolina interpret existing child endangerment and chemical endangerment laws to allow the prosecution of drug-using pregnant women. Eighteen states consider drug use during pregnancy to be a form of child abuse.

Four states, North Dakota, Minnesota, Iowa, and Kentucky, require hospitals to test both mothers and their children if medical professionals suspect drug use. In Minnesota and North Dakota, testing is mandated if drug-related complications occur at birth. Three states, Minnesota, South Dakota, and Wisconsin, allow pregnant women who use drugs to be involuntarily committed to a treatment program.

Some states are revising their laws to divert substance-exposed infants who are not at risk of abuse or neglect from the child welfare system. Connecticut was the first state to implement a dual-reporting pathway, which allows for anonymous reporting to meet federal requirements while separately evaluating concerns about abuse and neglect. Other states, like Massachusetts, are working on legislation to protect mothers treating substance use disorder with prescribed medications from child welfare investigations.

Child abuse prevention laws vary across states and hospital systems. While some states consider a newborn testing positive for drugs to be grounds for removing the child from maternal custody, others focus on providing treatment to help mothers overcome addiction.

shunhospital

Reporting procedures

In most states, OBGYN physicians and hospital workers do report failed drug screens and even suspected drug use of pregnant women to state agencies. However, alcohol use is less likely to be reported. While reporting is not always mandated, it can give pregnant women the resources to stop the substance use while still pregnant.

In Iowa, substance use during pregnancy is classified as child abuse, and health care providers are mandated to report that abuse to the state's child protective services system. In Texas, there is a program called Pregnant and Parenting Intervention (PPI) that can help women get treatment and resources. Texas is generally much harsher with these laws than other states. All newborns are given a toxicology screen as part of a routine newborn physical assessment, which shows exposure to drugs, alcohol and MAT medications. Hospitals are required to report any exposures to Child Protective Services (CPS) under the Child Abuse Prevention and Treatment Act (CAPTA).

Some hospitals are changing their response when babies are born exposed to drugs. For example, Massachusetts' largest health care system, Mass General Brigham, announced that it will no longer report suspected abuse or neglect to state welfare officials simply because a baby is born exposed to drugs. Instead, a report will be triggered only if there is reasonable cause to believe that the infant is "suffering or at imminent risk of suffering physical or emotional injury."

In most cases, it is up to doctors and hospital protocol to determine when to perform drug tests. Hospitals typically take a risk-based approach to testing infants. Medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of substance abuse.

shunhospital

The topic of drug testing newborns is a complex and sensitive issue, with legal, ethical, and medical implications. While there is no federal law mandating hospitals to drug test newborns, individual states have their own legislation and hospital protocols that guide this process. The issue of patient consent is at the heart of this matter, and it varies across different states and hospitals.

In Alabama, for instance, there have been reports of hospitals quietly drug testing new mothers without their explicit consent. The consent forms used by these hospitals have been criticised by medical ethicists as being unclear and not meeting the standards for informed consent. On the other hand, hospitals in Iowa and several other states routinely conduct drug screenings on newborns, and patient consent is not always required for these tests. This is because substance use during pregnancy is considered child abuse in Iowa, and healthcare providers are mandated to report it to Child Protective Services.

The American College of Obstetricians and Gynecologists (ACOG) provides guidance that drug testing should only be performed with the patient's consent. They emphasise that pregnant women must be informed of the potential consequences of a positive test result, including mandatory reporting requirements. Hospitals like UAB Hospital in Alabama adhere closely to ACOG guidelines, using separate forms to seek consent for drug testing, allowing women to opt out by not signing.

However, the lack of standardised consent forms and policies across hospitals contributes to inconsistencies in patient consent. Some hospitals have been criticised for opaque testing policies, making it challenging for patients to understand their rights and provide truly informed consent. This lack of transparency can lead to unexpected repercussions for mothers, including involvement with child protective services, criminal charges, and even loss of custody of their children.

To address these concerns, patients can take proactive steps to protect their rights and make informed decisions. They can request that hospital policies regarding drug testing be explained to them or ask for this information in writing. Patients can also seek consultation with patient advocates or the hospital's ethics committee to better understand their rights and options. Additionally, reviewing and obtaining medical records can provide valuable documentation of past treatments and consent provided. These steps can help ensure that patients are aware of the potential consequences of drug testing and can make informed choices regarding their healthcare and the well-being of their newborns.

Frequently asked questions

Hospitals do not universally screen newborns for drugs, but it is common for newborns to be given a toxicology screen as part of a routine newborn physical assessment, which can detect exposure to drugs, alcohol, and MAT medications. Hospitals are required to report any exposures to Child Protective Services (CPS).

If a newborn tests positive for drugs, this triggers an investigation by the Department of Children and Family Services (DCFS). An investigator will conduct a risk assessment, which includes evaluating the home environment and the caregiver. If there are risk factors, DCFS can take temporary protective custody of the child.

Generally, physicians are supposed to have informed consent before drug testing. However, in some states, providers don't need consent to conduct drug testing on newborns, and drug testing without consent does happen.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment